Billionaire entrepreneur Mark Cuban said generic medicines are already competitively priced in the U.S., while pharmacy benefit managers are making it harder for consumers to access cheaper brand-name drugs.
Cuban Targets PBMs On Tuesday, Cuban made the comments in a post on X while discussing prescription drug prices.
"Actually, our prices on generics are lower than most of the world," Cuban said.
He added, "We get requests to buy from everywhere." He said his company does not sell many brand-name medicines because Pharmacy Benefit Managers (PBMs) "won't allow manufacturers to sell to us." Cuban argued that his company could potentially offer some brand-name drugs at significantly lower prices if manufacturers were able to sell them through his platform.
"For many of those brand meds, if we could sell at our 15% markup, we would be at or near their pricing and in some cases lower," he said.
